NCT00250237View on ClinicalTrials.gov

Post-operative Haloperidol Versus Placebo for Prevention of Post-operative Delirium After Acute Hip Surgery

PHASE3CompletedINTERVENTIONAL

Enrollment

220

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

November 30, 2008

Study Completion Date

February 28, 2009

Conditions

Post-Operative DeliriumHip Fracture

Interventions

DRUG

Haloperidol

Haloperidol 1mg twice daily during 72hours

DRUG

placebo

Placebo 1mg twice daily during 72hours

Trial Locations (1)

2597 AX

Bronovo Hospital, The Hague

All Listed Sponsors

lead

Bronovo Hospital

OTHER

NCT00250237 - Post-operative Haloperidol Versus Placebo for Prevention of Post-operative Delirium After Acute Hip Surgery | Biotech Hunter | Biotech Hunter